319 related articles for article (PubMed ID: 12909504)
1. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.
Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Ferlini F; Perri T; Parmegiani L
Fertil Steril; 2003 Aug; 80(2):390-7. PubMed ID: 12909504
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes.
Kilani Z; Dakkak A; Ghunaim S; Cognigni GE; Tabarelli C; Parmegiani L; Filicori M
Hum Reprod; 2003 Jun; 18(6):1194-9. PubMed ID: 12773445
[TBL] [Abstract][Full Text] [Related]
3. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
4. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration.
Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Spettoli D; Taraborrelli S; Ciampaglia W
Hum Reprod; 2002 Aug; 17(8):2009-15. PubMed ID: 12151429
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
[TBL] [Abstract][Full Text] [Related]
6. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation.
Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; Tabarelli De Fatis C; Pocognoli P; Cantelli B; Boschi S
J Clin Endocrinol Metab; 2001 Jan; 86(1):337-43. PubMed ID: 11232021
[TBL] [Abstract][Full Text] [Related]
7. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
8. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
9. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
Lee KL; Couchman GM; Walmer DK
J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221
[TBL] [Abstract][Full Text] [Related]
10. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
11. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
12. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
[TBL] [Abstract][Full Text] [Related]
13. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
14. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
[TBL] [Abstract][Full Text] [Related]
15. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
16. Adding human menopausal gonadotrophin to antagonist protocols - is there a benefit?
Martin-Johnston M; Beltsos AN; Grotjan HE; Uhler ML
Reprod Biomed Online; 2007 Aug; 15(2):161-8. PubMed ID: 17697491
[TBL] [Abstract][Full Text] [Related]
17. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
18. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
van Wely M; Westergaard LG; Bossuyt PM; van der Veen F
Fertil Steril; 2003 Nov; 80(5):1086-93. PubMed ID: 14607553
[TBL] [Abstract][Full Text] [Related]
20. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
